Image of corn field
Book Excerpt from Endangered Maize
In Chapter 7, “Grow,” author Helen Anne Curry relays the story of Indigenous revolutionaries in Mexico who tapped into community-based methods to conserve traditional corn varieties.
Book Excerpt from Endangered Maize
Book Excerpt from Endangered Maize

In Chapter 7, “Grow,” author Helen Anne Curry relays the story of Indigenous revolutionaries in Mexico who tapped into community-based methods to conserve traditional corn varieties.

In Chapter 7, “Grow,” author Helen Anne Curry relays the story of Indigenous revolutionaries in Mexico who tapped into community-based methods to conserve traditional corn varieties.

  1. Home
  2. Subjects
  3. agribusiness
agribusiness
Cover of Endangered Maize by Helen Anne Curry
Opinion: Going Beyond Seed Banks
Helen Anne Curry | Jan 17, 2022
Rethinking why and how we conserve crop genetic diversity
a tractor moves through a green field
Book Excerpt from Resetting the Table
Robert Paarlberg | Feb 3, 2021
In his book’s introduction, author Robert Paarlberg advocates for the use of modern science in agriculture.
Genetically Modified Wheat Found in a Field in Washington State
Catherine Offord | Jun 9, 2019
The unapproved crop is resistant to glyphosate in the weedkiller Roundup, but doesn’t seem to have entered the food supply.
bio business
Companies Use CRISPR to Improve Crops
Ashley P. Taylor | Feb 1, 2019
The agritech industry is editing plant genomes to feed a growing population, expand the produce aisle, and make tastier, more convenient food products.
Monsanto and Bayer Announce Approval of Massive Merger
Bob Grant | Dec 13, 2016
On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.
Monsanto Buys Rights to CRISPR
Jef Akst | Sep 27, 2016
The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.
Bayer Looks to Buy Monsanto
Bob Grant | Sep 14, 2016
The US agribusiness behemoth agreed to a $57 billion buyout offer from the European pharmaceutical giant.